Literature DB >> 16014973

A new common integration site, Int7, for the mouse mammary tumor virus in mouse mammary tumors identifies a gene whose product has furin-like and thrombospondin-like sequences.

William Lowther1, Korah Wiley, Gilbert H Smith, Robert Callahan.   

Abstract

A novel common integration site for the mouse mammary tumor virus (MMTV) was identified (designated Int7) in five independently arising mouse mammary tumors. The insertion sites all cluster within a 1-kb region that is 2 to 3 kb 5' of the transcription initiation site of a gene, 2610028F08RIK, whose gene product contains furin-like and thrombospondin-like sequences. Expression of Int7 is normally very low or silent during various stages of mammary gland development, but MMTV integration at this site results in the activation of high steady-state levels of expression of the gene. These five tumors were also found to have two or three additional viral insertions, which in each case occurred flanking a member of either the Wnt and/or FGF gene family. Reverse transcriptase PCR results demonstrated that each of the viral insertions led to elevated expression of the presumed target flanking genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014973      PMCID: PMC1181551          DOI: 10.1128/JVI.79.15.10093-10096.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs.

Authors:  Y Okazaki; M Furuno; T Kasukawa; J Adachi; H Bono; S Kondo; I Nikaido; N Osato; R Saito; H Suzuki; I Yamanaka; H Kiyosawa; K Yagi; Y Tomaru; Y Hasegawa; A Nogami; C Schönbach; T Gojobori; R Baldarelli; D P Hill; C Bult; D A Hume; J Quackenbush; L M Schriml; A Kanapin; H Matsuda; S Batalov; K W Beisel; J A Blake; D Bradt; V Brusic; C Chothia; L E Corbani; S Cousins; E Dalla; T A Dragani; C F Fletcher; A Forrest; K S Frazer; T Gaasterland; M Gariboldi; C Gissi; A Godzik; J Gough; S Grimmond; S Gustincich; N Hirokawa; I J Jackson; E D Jarvis; A Kanai; H Kawaji; Y Kawasawa; R M Kedzierski; B L King; A Konagaya; I V Kurochkin; Y Lee; B Lenhard; P A Lyons; D R Maglott; L Maltais; L Marchionni; L McKenzie; H Miki; T Nagashima; K Numata; T Okido; W J Pavan; G Pertea; G Pesole; N Petrovsky; R Pillai; J U Pontius; D Qi; S Ramachandran; T Ravasi; J C Reed; D J Reed; J Reid; B Z Ring; M Ringwald; A Sandelin; C Schneider; C A M Semple; M Setou; K Shimada; R Sultana; Y Takenaka; M S Taylor; R D Teasdale; M Tomita; R Verardo; L Wagner; C Wahlestedt; Y Wang; Y Watanabe; C Wells; L G Wilming; A Wynshaw-Boris; M Yanagisawa; I Yang; L Yang; Z Yuan; M Zavolan; Y Zhu; A Zimmer; P Carninci; N Hayatsu; T Hirozane-Kishikawa; H Konno; M Nakamura; N Sakazume; K Sato; T Shiraki; K Waki; J Kawai; K Aizawa; T Arakawa; S Fukuda; A Hara; W Hashizume; K Imotani; Y Ishii; M Itoh; I Kagawa; A Miyazaki; K Sakai; D Sasaki; K Shibata; A Shinagawa; A Yasunishi; M Yoshino; R Waterston; E S Lander; J Rogers; E Birney; Y Hayashizaki
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

2.  Novel use of polymerase chain reaction to amplify cellular DNA adjacent to an integrated provirus.

Authors:  J Silver; V Keerikatte
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

3.  A new common integration region (int-3) for mouse mammary tumor virus on mouse chromosome 17.

Authors:  D Gallahan; C Kozak; R Callahan
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

Review 4.  MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways.

Authors:  R Callahan; G H Smith
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

5.  Large-scale identification of novel potential disease loci in mouse leukemia applying an improved strategy for cloning common virus integration sites.

Authors:  Marieke Joosten; Yolanda Vankan-Berkhoudt; Marjolein Tas; Monja Lunghi; Yvonne Jenniskens; Evan Parganas; Peter J M Valk; Bob Löwenberg; Eric van den Akker; Ruud Delwel
Journal:  Oncogene       Date:  2002-10-17       Impact factor: 9.867

6.  RTCGD: retroviral tagged cancer gene database.

Authors:  Keiko Akagi; Takeshi Suzuki; Robert M Stephens; Nancy A Jenkins; Neal G Copeland
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

7.  Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice.

Authors:  H Kwan; V Pecenka; A Tsukamoto; T G Parslow; R Guzman; T P Lin; W J Muller; F S Lee; P Leder; H E Varmus
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

8.  High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas.

Authors:  Min Sun Shin; Torgny N Fredrickson; Janet W Hartley; Takeshi Suzuki; Keiko Akagi; Keiko Agaki; Herbert C Morse
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

9.  Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4.

Authors:  G M Shackleford; C A MacArthur; H C Kwan; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

10.  Large-scale identification of disease genes involved in acute myeloid leukemia.

Authors:  Stefan J Erkeland; Marijke Valkhof; Claudia Heijmans-Antonissen; Antoinette van Hoven-Beijen; Ruud Delwel; Mirjam H A Hermans; Ivo P Touw
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more
  27 in total

Review 1.  The R-spondin protein family.

Authors:  Wim B M de Lau; Berend Snel; Hans C Clevers
Journal:  Genome Biol       Date:  2012       Impact factor: 13.583

Review 2.  Wnt signaling in mammary glands: plastic cell fates and combinatorial signaling.

Authors:  Caroline M Alexander; Shruti Goel; Saja A Fakhraldeen; Soyoung Kim
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-10-01       Impact factor: 10.005

3.  Selection of early-occurring mutations dictates hormone-independent progression in mouse mammary tumor lines.

Authors:  Albana Gattelli; María N Zimberlin; Roberto P Meiss; Lucio H Castilla; Edith C Kordon
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

4.  Rspo2/Int7 regulates invasiveness and tumorigenic properties of mammary epithelial cells.

Authors:  Malgorzata Klauzinska; Bolormaa Baljinnyam; Ahmed Raafat; Jaime Rodriguez-Canales; Luigi Strizzi; Yoshimi Endo Greer; Jeffrey S Rubin; Robert Callahan
Journal:  J Cell Physiol       Date:  2012-05       Impact factor: 6.384

Review 5.  Secreted and transmembrane wnt inhibitors and activators.

Authors:  Cristina-Maria Cruciat; Christof Niehrs
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

6.  RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.

Authors:  Kendra S Carmon; Xing Gong; Jing Yi; Anthony Thomas; Qingyun Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

Review 7.  Cellular signaling and biological functions of R-spondins.

Authors:  Jeong Kyo Yoon; Jin-Seon Lee
Journal:  Cell Signal       Date:  2011-10-01       Impact factor: 4.315

8.  R-spondin 2 promotes proliferation and migration via the Wnt/β-catenin pathway in human hepatocellular carcinoma.

Authors:  Xinguang Yin; Huixing Yi; Linlin Wang; Wanxin Wu; Xiaojun Wu; Linghua Yu
Journal:  Oncol Lett       Date:  2017-06-07       Impact factor: 2.967

9.  Loss-of-function point mutations and two-furin domain derivatives provide insights about R-spondin2 structure and function.

Authors:  Sheng-Jian Li; Ten-Yang Yen; Yoshimi Endo; Malgorzata Klauzinska; Bolormaa Baljinnyam; Bruce Macher; Robert Callahan; Jeffrey S Rubin
Journal:  Cell Signal       Date:  2009-06       Impact factor: 4.315

Review 10.  Common integration sites for MMTV in viral induced mouse mammary tumors.

Authors:  Robert Callahan; Gilbert H Smith
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-08-15       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.